Exclusive invite-only event
16 July 10:00 – 12:00 CEST
Agenda
10:00 Welcome
10:05 Participants’ round of introduction
10:15 Keynote: Stefan Brunnschweiler and Dr. Thomas Meyding
10:40 Firsthand experience: Jonathan Marsh
10:50 Open discussion
- Think thank
- Deepening of the discussion
- Sharing best practices
11:45 Final thoughts
Through examining the legal implications of the COVID-19 pandemic on M&A transactions in Western Europe, CMS has identified key issues impacting M&A deals, ranging from the possibility to terminate or postpone pending transactions to the impact of several state aid programmes. Though changes are happening on a day-to-day basis, the COVID-19 pandemic also seems to create new opportunities for distressed M&A, strategic buyers, private equity and financial sponsors. During this session, CMS will highlight aspects to be considered, when assessing and negotiating M&A transactions in the COVID-19 era.
Furthermore, the session will include a discussion on what comparisons can be made from the financial crisis 2008/2009 by analysing deal points of more than 4,600 M&A transactions CMS has been advising on since 2007. These deal points are the basis of CMS’ European M&A Study, published yearly and which provides insight into the legal provisions of M&A agreements, makes comparisons across Europe and with the US, and identifies market trends.
Speakers
Jonathan Marsh
President of ECLA
Vice President, International General Counsel, Total Marketing Services
Discussion Materials
Please find the components used during the roundtable below, together with the contact information of the speakers, should you wish to contact them in the future. In addition, please find two recent in-depth reports on the status of M&A activities in Europe.
